A specific antidote for dabigatran: functional and structural characterization.
Schiele F, van Ryn J, Canada K, Newsome C, Sepulveda E, Park J, Nar H, Litzenburger T.
Blood · journal article · DOI 10.1182/blood-2012-11-468207 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för dabigatran etexilate. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
22 hitsEfficacy of delayed thromboprophylaxis with dabigatran: pooled analysis.
Eriksson BI, Dahl OE, Rosencher N, Clemens A, Hantel S, Kurth AA.
Thromb Res · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.thromres.2012.08.315Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin.
Härtter S, Koenen-Bergmann M, Sharma A, Nehmiz G, Lemke U, Timmer W, Reilly PA.
Br J Clin Pharmacol · controlled clinical trial; research support, non-u.s. gov't; research-article; journal article · DOI 10.1111/j.1365-2125.2012.04218.xPharmacokinetic and pharmacodynamic effects of comedication of clopidogrel and dabigatran etexilate in healthy male volunteers.
Härtter S, Sennewald R, Schepers C, Baumann S, Fritsch H, Friedman J.
Eur J Clin Pharmacol · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1007/s00228-012-1304-8Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the Netherlands.
Postma MJ, Kappelhoff BS, van Hulst M, Brouwers JR.
J Med Econ · comparative study; research support, non-u.s. gov't; journal article · DOI 10.3111/13696998.2012.691144Rectal bleeding and hemostatic disorders induced by dabigatran etexilate in 2 elderly patients.
Béné J, Saïd W, Rannou M, Deheul S, Coupe P, Gautier S.
Ann Pharmacother · journal article; case reports · DOI 10.1345/aph.1q705Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding.
Friedman RJ, Kurth A, Clemens A, Noack H, Eriksson BI, Caprini JA.
Thromb Haemost · clinical trial, phase iii; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1160/th11-08-0589Dabigatran etexilate: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.
Burness CB, McKeage K.
Drugs · review; journal article · DOI 10.2165/11209080-000000000-00000Prescribing trends for dabigatran etexilate in primary care.
McCullagh L, Barry M.
Ir Med J · journal articleHemopericardium in a patient treated with dabigatran etexilate.
Barton CA, McMillian WD, Raza SS, Keller RE.
Pharmacotherapy · journal article; case reports · DOI 10.1002/j.1875-9114.2012.01036.xCost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation.
Kansal AR, Sorensen SV, Gani R, Robinson P, Pan F, Plumb JM, Cowie MR.
Heart · comparative study; research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.1136/heartjnl-2011-300646Plasma-diluted thrombin time to measure dabigatran concentrations during dabigatran etexilate therapy.
Avecilla ST, Ferrell C, Chandler WL, Reyes M.
Am J Clin Pathol · journal article · DOI 10.1309/ajcpau7oqm0srpzq[Clinical studies, the interests and limits of using dabigatran in atrial fibrillation].
Sternotte A, Douxfils J, Chatelain B, Chatelain C, Mullier F, Dogné JM, Spinewine A.
J Pharm Belg · review; journal article; english abstractDabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice.
Huisman MV, Lip GY, Diener HC, Brueckmann M, van Ryn J, Clemens A.
Thromb Haemost · review; journal article · DOI 10.1160/th11-10-0718Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment.
Watanabe M, Siddiqui FM, Qureshi AI.
Neurocrit Care · research support, non-u.s. gov't; review; journal article; research support, n.i.h., extramural · DOI 10.1007/s12028-011-9591-ySwitching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile.
Clemens A, van Ryn J, Sennewald R, Yamamura N, Stangier J, Feuring M, Härtter S.
Eur J Clin Pharmacol · controlled clinical trial; clinical trial; research support, non-u.s. gov't; research-article; clinical trial, phase i; journal article · DOI 10.1007/s00228-011-1205-2Oral thromboprophylaxis following total hip or knee replacement: review and multicentre experience with dabigatran etexilate.
Kendoff D, Perka C, Fritsche HM, Gehrke T, Hube R.
Open Orthop J · research-article; journal article · DOI 10.2174/1874325001105010395A Patient's Guide to Taking Dabigatran Etexilate.
Spinler SA, Willey VJ.
Circulation · patient education handout; journal article · DOI 10.1161/circulationaha.111.019786Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice.
Wilcox R, Pendleton RC, Smock KJ, Rodgers GM.
Hosp Pract (1995) · review; journal article · DOI 10.3810/hp.2011.08.576Spotlight on dabigatran etexilate in the prevention of stroke and systemic embolism in patients with atrial fibrillation.
Garnock-Jones KP.
Drugs Aging · journal article · DOI 10.2165/11207020-000000000-00000Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves.
McKellar SH, Abel S, Camp CL, Suri RM, Ereth MH, Schaff HV.
J Thorac Cardiovasc Surg · comparative study; journal article · DOI 10.1016/j.jtcvs.2011.02.011Dabigatran etexilate: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.
Garnock-Jones KP.
Am J Cardiovasc Drugs · journal article · DOI 10.2165/11206400-000000000-00000